Biobased farnesene producer Amyris (Emeryville, CA) reported a net loss of $32.3 million for its fiscal first-quarter ended 31 March compared with a net loss of $94.9 million in the year-ago quarter. Net loss attributable to Amyris stockholders of 44 cts/share fell short of a net loss of 38 cts/share consensus of analyst estimates compiled by Thomson Reuters (New York). Revenue decreased 73.2%, to $7.9 million, reflecting the company’s exit from ethanol and ethanol-blended gasoline trading in 2012. Renewable product sales increased 25.0%, to $3.0 million...
Already an IHS Chemical Week member? Login here
Forgot your user ID or password? Click here to have it sent to you.
Click here for 6 months access to the lates news, data and statistics on sustainability. PLUS all the news and analysis from the Chemical Week editorial team updated everyday on IHS Chemical Week